Is Semaglutide Cost-Effective for the Secondary Prevention of Cardiovascular Disease in People with Overweight or Obesity in Australia?
Autor: | Zomer, E., Zhou, J., Nelson, A., Nicholls, S., Stub, D., Zoungas, S. |
---|---|
Zdroj: | In Heart, Lung and Circulation August 2024 33 Supplement 4:S523-S523 |
Databáze: | ScienceDirect |
Externí odkaz: |